Cargando…

Changes in dementia diagnoses in Sweden during the COVID-19 pandemic

INTRODUCTION: The COVID-19 pandemic has caused large disruptions to healthcare systems. Refocus on COVID-19 related care might have contributed to indirect effects on other healthcare areas. Care focused on acute conditions have been negatively affected although research into the effects on chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Axenhus, Michael, Schedin-Weiss, Sophia, Tjernberg, Lars, Wimo, Anders, Eriksdotter, Maria, Bucht, Gustaf, Winblad, Bengt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039601/
https://www.ncbi.nlm.nih.gov/pubmed/35473668
http://dx.doi.org/10.1186/s12877-022-03070-y
_version_ 1784694162519490560
author Axenhus, Michael
Schedin-Weiss, Sophia
Tjernberg, Lars
Wimo, Anders
Eriksdotter, Maria
Bucht, Gustaf
Winblad, Bengt
author_facet Axenhus, Michael
Schedin-Weiss, Sophia
Tjernberg, Lars
Wimo, Anders
Eriksdotter, Maria
Bucht, Gustaf
Winblad, Bengt
author_sort Axenhus, Michael
collection PubMed
description INTRODUCTION: The COVID-19 pandemic has caused large disruptions to healthcare systems. Refocus on COVID-19 related care might have contributed to indirect effects on other healthcare areas. Care focused on acute conditions have been negatively affected although research into the effects on chronic and care intensive patient groups such as patients with dementia diseases is lacking. In this study we evaluated dementia diagnosis trends in Sweden during 2015–2020 according to International Classification of Disease version 10 coding of common dementia diseases. METHODS: Regional and national statistics in the form of International Classification of Disease version 10 coding, COVID-19 incidence, mortality data, and population census data were collected from the National Institute of Health and Welfare. Logistic regression analysis was performed to identify trends of dementia diagnosis during 2015–2020. Correlation test was performed between COVID-19 incidence, mortality rates, and dementia coding. RESULTS: Dementia diagnosis incidence has been declining since 2015 and further decline was noted in many regions in Sweden during 2020. As COVID-19 incidence increased, fewer cases of dementia were diagnosed, a decrease that differentially impacted women and those who were advanced in age. CONCLUSIONS: Dementia diagnosis incidence in Sweden has been on a decline since 2015. The COVID-19 pandemic caused a further larger decline in dementia diagnosis incidence during 2020. COVID-19 incidence, but not mortality, was associated with decrease in dementia diagnosis incidence. There might be a large number of undiagnosed patients with dementia and healthcare reforms should be enacted to address this. Women and elderly are particularly vulnerable groups. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-022-03070-y.
format Online
Article
Text
id pubmed-9039601
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90396012022-04-26 Changes in dementia diagnoses in Sweden during the COVID-19 pandemic Axenhus, Michael Schedin-Weiss, Sophia Tjernberg, Lars Wimo, Anders Eriksdotter, Maria Bucht, Gustaf Winblad, Bengt BMC Geriatr Research INTRODUCTION: The COVID-19 pandemic has caused large disruptions to healthcare systems. Refocus on COVID-19 related care might have contributed to indirect effects on other healthcare areas. Care focused on acute conditions have been negatively affected although research into the effects on chronic and care intensive patient groups such as patients with dementia diseases is lacking. In this study we evaluated dementia diagnosis trends in Sweden during 2015–2020 according to International Classification of Disease version 10 coding of common dementia diseases. METHODS: Regional and national statistics in the form of International Classification of Disease version 10 coding, COVID-19 incidence, mortality data, and population census data were collected from the National Institute of Health and Welfare. Logistic regression analysis was performed to identify trends of dementia diagnosis during 2015–2020. Correlation test was performed between COVID-19 incidence, mortality rates, and dementia coding. RESULTS: Dementia diagnosis incidence has been declining since 2015 and further decline was noted in many regions in Sweden during 2020. As COVID-19 incidence increased, fewer cases of dementia were diagnosed, a decrease that differentially impacted women and those who were advanced in age. CONCLUSIONS: Dementia diagnosis incidence in Sweden has been on a decline since 2015. The COVID-19 pandemic caused a further larger decline in dementia diagnosis incidence during 2020. COVID-19 incidence, but not mortality, was associated with decrease in dementia diagnosis incidence. There might be a large number of undiagnosed patients with dementia and healthcare reforms should be enacted to address this. Women and elderly are particularly vulnerable groups. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-022-03070-y. BioMed Central 2022-04-26 /pmc/articles/PMC9039601/ /pubmed/35473668 http://dx.doi.org/10.1186/s12877-022-03070-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Axenhus, Michael
Schedin-Weiss, Sophia
Tjernberg, Lars
Wimo, Anders
Eriksdotter, Maria
Bucht, Gustaf
Winblad, Bengt
Changes in dementia diagnoses in Sweden during the COVID-19 pandemic
title Changes in dementia diagnoses in Sweden during the COVID-19 pandemic
title_full Changes in dementia diagnoses in Sweden during the COVID-19 pandemic
title_fullStr Changes in dementia diagnoses in Sweden during the COVID-19 pandemic
title_full_unstemmed Changes in dementia diagnoses in Sweden during the COVID-19 pandemic
title_short Changes in dementia diagnoses in Sweden during the COVID-19 pandemic
title_sort changes in dementia diagnoses in sweden during the covid-19 pandemic
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039601/
https://www.ncbi.nlm.nih.gov/pubmed/35473668
http://dx.doi.org/10.1186/s12877-022-03070-y
work_keys_str_mv AT axenhusmichael changesindementiadiagnosesinswedenduringthecovid19pandemic
AT schedinweisssophia changesindementiadiagnosesinswedenduringthecovid19pandemic
AT tjernberglars changesindementiadiagnosesinswedenduringthecovid19pandemic
AT wimoanders changesindementiadiagnosesinswedenduringthecovid19pandemic
AT eriksdottermaria changesindementiadiagnosesinswedenduringthecovid19pandemic
AT buchtgustaf changesindementiadiagnosesinswedenduringthecovid19pandemic
AT winbladbengt changesindementiadiagnosesinswedenduringthecovid19pandemic